Biodesix To Use Sapio's LIMS | GenomeWeb

NEW YORK (GenomeWeb News) - Sapio Sciences said today that molecular diagnostics developer Biodesix has purchased its Exemplar laboratory information management system.

Biodesix is developing mass spectrometry-based molecular diagnostics to help physicians diagnose, treat, and monitor disease.

Sapio said that the company was looking for a LIMS that could track samples, support biobanking, and integrate with its mass spectrometry instruments.

Financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.